Plexus CORP (PLXS) — SEC Filings
Latest SEC filings for Plexus CORP. Recent DEF 14A filing on Dec 22, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
Overview
Plexus CORP (PLXS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEF 14A filed on Dec 22, 2025: Plexus Corp. (PLXS) reported robust fiscal year 2025 highlights, achieving $4.03 billion in revenue and diluted earnings per share of $6.26. The company maintained a strong Return on Invested Capital (ROIC) of 14.6% and expanded its global footprint to 26 facilities across 7 countries, supported by
Sentiment Summary
Across 27 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 24 neutral. The dominant filing sentiment for Plexus CORP is neutral.
Filing Type Overview
Plexus CORP (PLXS) has filed 2 DEF 14A, 2 10-K, 14 8-K, 6 10-Q, 3 SC 13G/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent Filings (27)
-
Plexus Posts $4.03B Revenue, Sets Shareholder Meeting for Feb 2026
— DEF 14A · Dec 22, 2025 Risk: low
Plexus Corp. (PLXS) reported robust fiscal year 2025 highlights, achieving $4.03 billion in revenue and diluted earnings per share of $6.26. The company maintai -
Plexus Targets 15% ROIC Amidst Diversified Growth Strategy
— 10-K · Nov 14, 2025 Risk: medium
Plexus Corp. (PLXS) reported a fiscal year ended September 27, 2025, with a strategic focus on Aerospace/Defense, Healthcare/Life Sciences, and Industrial marke -
Plexus Corp. Files 8-K on Financials
— 8-K · Oct 22, 2025 Risk: low
On October 22, 2025, Plexus Corp. filed an 8-K report detailing results of operations and financial condition. The filing also included financial statements and -
Plexus Q3 Sales Dip 3.2% Amid Softening Demand, Net Income Down 14.8%
— 10-Q · Aug 1, 2025 Risk: medium
PLEXUS CORP reported a net sales decrease to $987.6 million for the third quarter ended June 28, 2025, down from $1.02 billion in the prior-year quarter, repres -
Plexus Corp. Files 8-K on Financials
— 8-K · Jul 23, 2025 Risk: low
On July 23, 2025, Plexus Corp. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits related -
Plexus Corp. Files 8-K Report
— 8-K · May 14, 2025 Risk: low
On May 14, 2025, Plexus Corp. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial f -
Plexus Corp. Files 10-Q for Q2 2025
— 10-Q · May 2, 2025 Risk: low
Plexus Corp. reported its second quarter results for the period ending March 29, 2025. The company's fiscal year ends on September 27. Key financial data and se -
Plexus Corp. Files 8-K on Financials
— 8-K · Apr 23, 2025 Risk: low
On April 23, 2025, Plexus Corp. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, provid -
Plexus Corp. Files 8-K on Shareholder Vote and Financials
— 8-K · Feb 12, 2025 Risk: low
On February 11, 2025, Plexus Corp. filed an 8-K report indicating that it submitted matters to a vote of its security holders and filed financial statements and -
Plexus Corp. Files 10-Q for Q1 2025
— 10-Q · Jan 31, 2025 Risk: low
Plexus Corp. reported its first quarter results for the period ending December 28, 2024. The company's fiscal year ends on September 27. Key financial details a -
Plexus Corp. Files 8-K on Financials
— 8-K · Jan 22, 2025 Risk: low
On January 22, 2025, Plexus Corp. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, prov -
Plexus Corp. Files 2025 Proxy Statement
— DEF 14A · Dec 13, 2024 Risk: low
Plexus Corp. filed its definitive proxy statement (DEF 14A) on December 13, 2024, for its 2025 annual meeting of stockholders, which will be held on February 11 -
Plexus Corp. Files 2024 Annual Report
— 10-K · Nov 15, 2024 Risk: low
Plexus Corp. filed its 10-K for the fiscal year ending September 28, 2024, reporting on its operations as a manufacturer of printed circuit boards. The company -
Plexus Corp. Files 8-K on Financials
— 8-K · Oct 23, 2024 Risk: low
On October 23, 2024, Plexus Corp. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits relat -
Plexus Corp. Files 8-K for Regulation FD and Exhibits
— 8-K · Aug 16, 2024 Risk: low
On August 14, 2024, Plexus Corp. filed an 8-K report to disclose information regarding Regulation FD and financial statements. The filing does not contain speci -
Plexus Corp. Files Q3 2024 10-Q
— 10-Q · Aug 2, 2024 Risk: low
Plexus Corp. reported its third-quarter results for the period ending June 29, 2024. The company's fiscal year ends on September 28, 2024. Specific financial fi -
Plexus Corp. Files 8-K with Financial Updates
— 8-K · Jul 24, 2024 Risk: low
On July 24, 2024, Plexus Corp. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, provid -
Plexus Corp. Files 8-K on Executive and Director Changes
— 8-K · Jun 5, 2024 Risk: low
On June 5, 2024, Plexus Corp. filed an 8-K report detailing changes in its executive and director positions. The filing includes information on the election of -
Plexus Corp. Files 10-Q for Period Ending March 30, 2024
— 10-Q · May 3, 2024 Risk: medium
PLEXUS CORP (PLXS) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Plexus Corp. filed a 10-Q report for the period ending March 30, 2024. The filin -
Plexus Corp. Files 8-K on Financials
— 8-K · Apr 24, 2024 Risk: low
On April 24, 2024, Plexus Corp. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits related -
Plexus Corp. Files 8-K on Officer Changes, Bylaws, and Shareholder Votes
— 8-K · Feb 15, 2024 Risk: medium
PLEXUS CORP filed an 8-K on February 15, 2024, reporting events that occurred on February 14, 2024. The filing indicates that the company addressed potential ch -
Vanguard Trims Plexus Stake to 14.9% as of Dec 29, 2023
— SC 13G/A · Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amendment to its SC 13G filing on February 13, 2024, indicating its ownership of 4,046,785 shares of Plexu -
Dimensional Fund Advisors LP Reports 1.68M Shares in Plexus Corp
— SC 13G/A · Feb 9, 2024 Risk: low
Dimensional Fund Advisors LP, a Delaware Limited Partnership, filed an amended SC 13G/A on February 9, 2024, indicating a change in their beneficial ownership o -
Plexus Corp. Files 10-Q for Period Ending December 30, 2023
— 10-Q · Feb 2, 2024 Risk: medium
PLEXUS CORP (PLXS) filed a Quarterly Report (10-Q) with the SEC on February 2, 2024. Plexus Corp. reported financial results for the period ending December 30, -
Plexus Corp. Files 8-K on Financial Results & Condition
— 8-K · Jan 24, 2024
Plexus Corp. filed an 8-K on January 24, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This fi -
BlackRock Amends PLEXUS CORP Stake, Files SC 13G/A
— SC 13G/A · Jan 22, 2024
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in its ownership of PLEXUS CORP's Common Stock as of December 31, 2023. This f -
Plexus Files 8-K for Regulation FD Disclosure & Exhibits
— 8-K · Jan 16, 2024
Plexus Corp. filed an 8-K on January 16, 2024, primarily to disclose information under Regulation FD and to include financial statements and exhibits. This fili
Risk Profile
Risk Assessment: Of PLXS's 24 recent filings, 0 were flagged as high-risk, 5 as medium-risk, and 19 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Angelo M. Ninivaggi
- Dean A. Foate
- Todd P. Kelsey
- Patrick J. Jermain
Industry Context
Plexus operates in the highly competitive Electronic Manufacturing Services (EMS) industry, serving demanding sectors like Aerospace/Defense, Healthcare/Life Sciences, and Industrial. Key trends include increasing complexity of products, stringent regulatory requirements, and a growing demand for integrated solutions across the product lifecycle. Competitors range from large global players to specialized regional providers, all vying for market share through innovation, quality, and cost-efficiency.
Top Tags
8-k (6) · financial-reporting (5) · 10-Q (5) · financial-results (4) · corporate-governance (4) · sec-filing (3) · financials (3) · institutional-ownership (3) · Electronics Manufacturing Services (2) · exhibits (2)
Executive Compensation
From the most recent DEF 14A filing (Dec 22, 2025):
- John P. Moran — President and Chief Executive Officer: $4,698,910
- Kevin J. Merfeld — Senior Vice President, Chief Financial Officer: $2,349,340
- Shawn G. Yates — Senior Vice President, Chief Operating Officer: $2,174,340
- Christopher J. W. Lytle — Senior Vice President, Chief Legal Officer and General Counsel: $1,799,340
- Ronald J. Schassburger — Senior Vice President, Chief Information Officer: $1,799,340
Key Numbers
- Revenue: $4.03B — Fiscal 2025 highlight, indicating strong financial performance
- Diluted earnings per share: $6.26 — Fiscal 2025 highlight, demonstrating profitability
- Return on Invested Capital (ROIC): 14.6% — Fiscal 2025 highlight, showing efficient capital utilization
- Shares of common stock outstanding: 26,759,184 — As of Record Date December 17, 2025, for voting eligibility
- Directors to be elected: 10 — Proposal 1 at the Annual Meeting
- BlackRock, Inc. ownership: 15.41% — Significant beneficial ownership as of March 31, 2025
- The Vanguard Group, Inc. ownership: 13.77% — Significant beneficial ownership as of September 30, 2025
- Directors with Financial & Accounting Experience: 9/10 — Board qualification, indicating strong financial oversight
- Directors with Global Business Experience: 10/10 — Board qualification, highlighting international market expertise
- Annual Meeting Date: February 18, 2026 — Key date for shareholder voting
- Target Annual Revenue Growth Rate: 9-12% — Plexus's long-term goal for revenue expansion.
- Target Return on Invested Capital (ROIC): 15% — A key financial metric Plexus aims to achieve, indicating efficient capital use.
- Weighted Average Cost of Capital (WACC): 8.9% — Plexus's cost of capital for fiscal 2025, against which ROIC is measured.
- Industrial Sector Net Sales: 43% — The largest contributor to Plexus's net sales in fiscal 2025.
- Healthcare/Life Sciences Net Sales: 40% — The second largest contributor to Plexus's net sales in fiscal 2025.
Forward-Looking Statements
- {"claim":"Vanguard's ownership percentage in Plexus Corp. will remain relatively stable, with minor fluctuations due to passive index fund adjustments.","entity":"The Vanguard Group","targetDate":"Next 12 months","confidence":"high"}
- {"claim":"Dimensional Fund Advisors LP will maintain a significant stake in Plexus Corp.","entity":"Dimensional Fund Advisors LP","targetDate":"Q3 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Plexus CORP (PLXS)?
Plexus CORP has 27 recent SEC filings from Jan 2024 to Dec 2025, including 14 8-K, 6 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PLXS filings?
Across 27 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 24 neutral. The dominant sentiment is neutral.
Where can I find Plexus CORP SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Plexus CORP (PLXS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Plexus CORP?
Key financial highlights from Plexus CORP's most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PLXS?
The investment thesis for PLXS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Plexus CORP?
Key executives identified across Plexus CORP's filings include Angelo M. Ninivaggi, Dean A. Foate, Todd P. Kelsey, Patrick J. Jermain.
What are the main risk factors for Plexus CORP stock?
Of PLXS's 24 assessed filings, 0 were flagged high-risk, 5 medium-risk, and 19 low-risk.
What are recent predictions and forward guidance from Plexus CORP?
Recent forward-looking statements from Plexus CORP include guidance on {"claim":"Vanguard's ownership percentage in Plexus Corp. will remain relatively stable, with minor fluctuations due to and 1 other predictions.